Literature DB >> 29308552

In vivo study of dermal collagen of striae distensae by confocal Raman spectroscopy.

Pam Wen Lung1, Vamshi Krishna Tippavajhala2, Thiago de Oliveira Mendes3, Claudio A Téllez-Soto3, Desirée Cigaran Schuck4, Carla Abdo Brohem4, Marcio Lorencini4, Airton Abrahão Martin5,6.   

Abstract

This research work mainly deals with studying qualitatively the changes in the dermal collagen of two forms of striae distensae (SD) namely striae rubrae (SR) and striae albae (SA) when compared to normal skin (NS) using confocal Raman spectroscopy. The methodology includes an in vivo human skin study for the comparison of confocal Raman spectra of dermis region of SR, SA, and NS by supervised multivariate analysis using partial least squares discriminant analysis (PLS-DA) to determine qualitatively the changes in dermal collagen. These groups are further analyzed for the extent of hydration of dermal collagen by studying the changes in the water content bound to it. PLS-DA score plot showed good separation of the confocal Raman spectra of dermis region into SR, SA, and NS data groups. Further analysis using loading plot and S-plot indicated the participation of various components of dermal collagen in the separation of these groups. Bound water content analysis showed that the extent of hydration of collagen is more in SD when compared to NS. Based on the results obtained, this study confirms the active involvement of dermal collagen in the formation of SD. It also emphasizes the need to study quantitatively the role of these various biochemical changes in the dermal collagen responsible for the variance between SR, SA, and NS.

Entities:  

Keywords:  Confocal Raman spectroscopy; Human dermal collagen; In vivo human skin study; Striae distensae

Mesh:

Substances:

Year:  2018        PMID: 29308552     DOI: 10.1007/s10103-017-2431-3

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  49 in total

1.  Extensive striae distensae as a result of topical corticosteroid therapy in psoriasis vulgaris.

Authors:  Christina Rogalski; Uwe-Frithjof Haustein; Hans-Jürgen Glander; Uwe Paasch
Journal:  Acta Derm Venereol       Date:  2003       Impact factor: 4.437

2.  Colored striae in adolescent children.

Authors:  W R SISSON
Journal:  J Pediatr       Date:  1954-11       Impact factor: 4.406

3.  Expression of estrogen, androgen, and glucocorticoid receptors in recent striae distensae.

Authors:  Raquel Cristina Tancsik Cordeiro; Karina Gotardello Zecchin; Aparecida Machado de Moraes
Journal:  Int J Dermatol       Date:  2010-01       Impact factor: 2.736

4.  Risk factors associated with striae gravidarum.

Authors:  Anne Lynn S Chang; Yolanda Z Agredano; Alexa Boer Kimball
Journal:  J Am Acad Dermatol       Date:  2004-12       Impact factor: 11.527

Review 5.  Striae distensae: a comprehensive review and evidence-based evaluation of prophylaxis and treatment.

Authors:  S Al-Himdani; S Ud-Din; S Gilmore; A Bayat
Journal:  Br J Dermatol       Date:  2014-03       Impact factor: 9.302

6.  Striae in normal men.

Authors:  R F Elton; H Pinkus
Journal:  Arch Dermatol       Date:  1966-07

7.  Histopathology of striae distensae, with special reference to striae and wound healing in the Marfan syndrome.

Authors:  H Pinkus; M K Keech; A H Mehregan
Journal:  J Invest Dermatol       Date:  1966-03       Impact factor: 8.551

8.  Clinical features and risk factors for striae distensae in Korean adolescents.

Authors:  S Cho; E S Park; D H Lee; K Li; J H Chung
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-10       Impact factor: 6.166

9.  Relationship between obesity and other risk factors and skin disease among adult Saudi population.

Authors:  Ghada M Khalil; Hani A Al Shobaili; Abdullateef Alzolibani; Ahmad Al Robaee
Journal:  J Egypt Public Health Assoc       Date:  2011

10.  Risk factors for the development of striae gravidarum.

Authors:  Hibah Osman; Nelly Rubeiz; Hala Tamim; Anwar H Nassar
Journal:  Am J Obstet Gynecol       Date:  2007-01       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.